Szubsztitúció
A heroin fenntartó programról:
Prof Jürgen Rehm PhD, Patrick Gschwend MA, Thomas Steffen MD, Prof Felix Gutzwiller MD, Anja Dobler-Mikola PhD and Prof Ambros Uchtenhagen MD: Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study, Lancet 2001; 358: 1417-1420
Frick U, Rehm J, Kovacic S, Ammann J, Uchtenhagen A. (2006)A prospective cohort study on orally administered heroin substitution for severely addicted opioid users. Addiction. 2006 Nov;101(11):1631-9.
Frick U, Rehm J, Kovacic S, Ammann J, Uchtenhagen A. (2006)A prospective cohort study on orally administered heroin substitution for severely addicted opioid users. Addiction. 2006 Nov;101(11):1631-9.
A heroin fenntartó programról:
Prof Jürgen Rehm PhD, Patrick Gschwend MA, Thomas Steffen MD, Prof Felix Gutzwiller MD, Anja Dobler-Mikola PhD and Prof Ambros Uchtenhagen MD: Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study, Lancet 2001; 358: 1417-1420
Frick U, Rehm J, Kovacic S, Ammann J, Uchtenhagen A. (2006)A prospective cohort study on orally administered heroin substitution for severely addicted opioid users. Addiction. 2006 Nov;101(11):1631-9.
Frick U, Rehm J, Kovacic S, Ammann J, Uchtenhagen A. (2006)A prospective cohort study on orally administered heroin substitution for severely addicted opioid users. Addiction. 2006 Nov;101(11):1631-9.








